HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Toots Its Own Horn On Safety Of Marketed Drugs, Imports

This article was originally published in The Tan Sheet

Executive Summary

FDA’s Global Engagement report describes the agency’s actions to protect the international supply chain. Meanwhile, the Advances in FDA’s Safety Program for Marketed Drugs report notes label changes and safety studies mandated under its post-market drug safety program.

You may also be interested in...

Regulatory News In Brief

FDA warns consumers of link between PPIs and clostridium difficile-associated diarrhea; FDA commissioner adopts transparency proposals; Wholistic Herbs herbal eye and nasal sprays on recall; more Regulatory News In Brief.

FDA Global Pharma Safety Plan Looks To Food Model

FDA seeks new authority over the international drug supply chain to support a global safety plan.

FDA Launches Safe Use Initiative; Details TBA Following Stakeholder Input

FDA expects to accomplish the goals of its Safe Use Initiative through a combination of voluntary moves by industry and regulatory activities

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts